2022

1. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

   Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4

2. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

   Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 725-734

3. Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry

   Frontiers in Medicine, Vol. 9